While decrying “alternate facts," @JoeNBC falsely claims “every study” shows hydroxychloroquine “doesn’t work” against Covid
@JoeNBC NYU’s Grossman school of Medicine study found patients given hydroxychloroquine and azithromycin at an early stage had a lower need for hospitalization than those who were not medrxiv.org/content/10.110…
@JoeNBC Yale Prof. Harvey Risch study “Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis” medrxiv.org/content/10.110…
@JoeNBC From a Brazilian study: there were “41% of deaths among those who did not choose [HCW] therapy and were hospitalized against 0% among those who chose by therapy.” covexit.com/new-brazilian-…
@JoeNBC A retrospective study of 2,541 Detroit cases showed up to 71% reduction in mortality in early treatment with hydroxychloroquine azithromycin. doi.org/10.1016/j.ijid…
A retrospective study of 3,737 cases in Marseille showed a reduction of 50% in mortality without any adverse effects in the Hydroxychloroquine and Azithromycin group. doi.org/10.1016/j.tmai…
A meta-analysis of 105,040 cases from 20 studies in 9 countries found a reduction in mortality by up to three times in groups treated early with Hydroxychloroquine and Azithromycin: doi.org/10.1016/j.nmni…
A study of 6,493 patients with COVID-19 at Mount Sinai Hospital, New York, showed that hydroxychloroquine helped to reduce mortality in hospitalized patients doi.org/10.1007/s11606…
A Henry Ford Health System (from Michigan) study "determined that hydroxychloroquine and azithromycin provided a 71% hazard ratio reduction.” ijidonline.com/article/S1201-…
A Mount Sinai study published in the Journal of General Internal Medicine found "hydroxychloroquine decreased mortality hazard ratio by 47% percent." doi.org/10.1007/s11606…
